How far will THOR drop if HTWR gets postive vote today
If HTWR gets a positive panel vote today how far will THOR drop.
More competition is not good for THOR. It seems as if HTWR does get FDA approval it is good for heart patients and surgeons as there are more choices but bad for THOR and HTWR because both companies will have to sell their products at much lower margins.
I recommend shorting both THOR and HTWR if HTWR gets FDA approval. But if HTWR does not get approval then THOR is still a good stock to buy.
Why would HTWR pay MORE THAN $8 million for a technology, and hire scientists ssociated with the technology while paying their salaries, health-care costs, pension costs, etc., UNLESS the technology is SUPERIOR to what HTWR has???
Certainly HTWR would be stupid doing the above if the technology was INFERIOR or EQUAL to what they have!!!
I can't make my thoughts any simpler. HTWR would not waste money or time.
My BOTTOM LINE is that the HeartMate III will crush the HVAD / MVAD technology and the HeartMate II will hold the line until then.
I am very proud of THOR for getting such a good deal. No termination costs that I am aware of. The legal filing is next to nothing. The design problems you mention is nothing but rampant unsubstantiated speculation. I could say the same thing about THOR and have just as much evidence as you do.
They bought maglev WHRT for the patents at a very cheap price, a no brainer. I think both companies can do well with the amount of growth in this space. I don't see HTWR cutting their price on their device, don't know about THOR.